NCT02519127

Brief Summary

This study is testing the effectiveness of a dietary intervention by means of measuring the change in RQ upon a hyperinsulinemic euglycemic clamp challenge and by means of measuring the kinetic responses of multiple PF markers (including RQ) to an acute mixed meal challenge before and after a 6-week dietary intervention. The challenges will be applied to investigate whether the kinetic response is a better measure for health and wellbeing when compared to fasting (baseline) levels. In addition, several measures that reflect perceivable benefits like mood, quality of life, sleep quality, cognitive and physical performance will be assessed in a first exploratory attempt to link (changes in) PF to consumer perceivable benefits. Subjects will be randomly allocated to a low glycemic load diet or a 'Western' diet for 6 weeks. Before and after the intervention several measurements will take place. The low glycemic load diet will be high in polyphenols, protein, vegetables, pulses, fibres and nuts, and low in glycemic carbohydrates. All these dietary factors have been shown to improve glycemic control and/or to reduce metabolic syndrome risk factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 10, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2017

Completed
Last Updated

November 9, 2017

Status Verified

November 1, 2017

Enrollment Period

1.9 years

First QC Date

July 7, 2015

Last Update Submit

November 8, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Metabolic flexibility, as measured by delta RQ (change in RQ) upon a hyperinsulinemic euglycemic clamp

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

Secondary Outcomes (5)

  • Metabolic flexibility, as measured by delta RQ (change in RQ) upon a mixed meal challenge

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Phenotypic flexibility markers, as measured by various blood parameters such as lipids, glucose, inflammatory markers and more, upon a mixed meal challenge

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Diet-induced changes in the Kinetic responses vs. the baseline values of RQ and various phenotypic flexibility parameters such as lipids, glucose, inflammatory markers and more

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Phenotypic flexibility markers, as measured by various blood parameters such as lipids, glucose, inflammatory markers and more, in the fasted state

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Insulin sensitivity, as measured by a hyperinsulinemic euglycemic clamp

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

Other Outcomes (8)

  • Functional markers of cognitive performance, as measured by attention, memory and executive function

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Functional markers of physical performance, as measured by the timed up-and-go test (TUGT), the 6-minute walk test, handgrip and muscle strength tests

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • Sleep quality, as assessed with the10-item Pittsburgh Sleep Quality Index

    Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention

  • +5 more other outcomes

Study Arms (2)

Low glycaemic load diet

EXPERIMENTAL

Subjects will be following a low glycaemic load diet, typically high in polyphenols, proteins, vegetables, pulses, fibres and nuts, and low in glycemic carbohydrates, for six continuous weeks.

Other: Low glycaemic load diet

Western diet

EXPERIMENTAL

Subjects will be following a western diet, typically high in saturated fat, refined sugars and salt, and low in fruit and vegetables and fibers, for six continuous weeks.

Other: Western diet

Interventions

Subjects will first be subjected to a 2-week run-in diet consisting of products that fit into a typical 'Western' diet. Thereafter subjects will be allocated to a low glycemic load diet for 6 weeks.

Low glycaemic load diet

Subjects will first be subjected to a 2-week run-in diet consisting of products that fit into a typical 'Western' diet. Thereafter subjects will be allocated to a 'Western' diet for 6 weeks.

Western diet

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Men and postmenopausal women: ≥ 50 and ≤ 70 years at the start of the study
  • Body mass index (BMI) ≥ 25.0 and ≤ 35.0 kg/m2
  • Healthy (as determined by dependent physician): no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases) as assessed by physical characteristics and health and lifestyle questionnaire
  • Fasting blood glucose value ≤ 6.9 mmol/litre at screening
  • Waist circumference \>94 cm for males, \>80 cm for females
  • Maximum 2.5 hours of moderate to vigorous physical activity per week (during last 3 months)
  • Agreeing to be informed about medically relevant personal test-results by a physician
  • Willing to comply to study protocol during study
  • Accessible veins on arms as determined by examination at screening

You may not qualify if:

  • Reported participation in another nutritional or biomedical trial three months before the pre-study examination or during the study
  • Blood donation in the past three months
  • Reported participation in night shift work two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM;
  • Consumption of \> 21 alcoholic units for males, \> 14 alcohol units for females in a typical week;
  • Reported use of any nicotine containing products in the six months preceding the study and during the study itself;
  • Reported dietary habits: medically prescribed diet, slimming diet, vegetarian;
  • People who are familiar with an allergy or intolerance to any of the provided food products
  • Reported weight loss or weight gain (10%) in the last six months prior to the pre-study screening;
  • Clinically relevant abnormalities in clinical chemistry at screening (to be judged by the study physician);
  • Being an employee of Unilever or the collaborating research departments in Maastricht University Medical Centre (MUMC+);
  • Taking medication, which may interfere with study measurements, as judged by the responsible physician;
  • Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Center

Maastricht, 6200 MD, Netherlands

Location

Related Publications (2)

  • Fechner E, Bilet L, Peters HPF, Schrauwen P, Mensink RP. A Whole-Diet Approach Affects Not Only Fasting but Also Postprandial Cardiometabolic Risk Markers in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2020 Nov 19;150(11):2942-2949. doi: 10.1093/jn/nxaa252.

  • Fechner E, Bilet L, Peters HPF, Hiemstra H, Jacobs DM, Op 't Eyndt C, Kornips E, Mensink RP, Schrauwen P. Effects of a whole diet approach on metabolic flexibility, insulin sensitivity and postprandial glucose responses in overweight and obese adults - A randomized controlled trial. Clin Nutr. 2020 Sep;39(9):2734-2742. doi: 10.1016/j.clnu.2019.12.010. Epub 2019 Dec 17.

MeSH Terms

Interventions

Diet, Western

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Patrick Schrauwen, Professor

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR
  • Ronald Mensink, Professor

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2015

First Posted

August 10, 2015

Study Start

July 1, 2015

Primary Completion

May 12, 2017

Study Completion

May 12, 2017

Last Updated

November 9, 2017

Record last verified: 2017-11

Locations